Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Transplantation|September 29, 2022
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver TransplantationAvesh J Thuluvath, Osama Siddiqui, Jennifer C Lai, et al.
Cardiovascular and Interventional Radiology|June 10, 2024
Percutaneous Biliary Interventions via the Modified Hutson Loop in Patients with Biliary-Enteric Anastomoses: A Retrospective StudyAli Husnain, Asad Malik, Juan Caicedo, et al.
Gastroenterology|January 31, 2012
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferonJosh Levitsky, Maria Isabel Fiel, John P Norvell, et al.
Academic Radiology|August 11, 2012
MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplantsRyan B Perumpail, Josh Levitsky, Yi Wang, et al.
Transplantation|July 27, 2023
Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant CandidatesAvesh J Thuluvath, Andres Duarte-Rojo, Jennifer C Lai, et al.
Journal of Palliative Medicine|April 27, 2026
Integrating Palliative Care in End-Stage Liver Disease: An Interprofessional Perspective on Communication, Terminology, and Educational GapsNivetha Saravanan, Daniel Ganger, Kenny Chen, et al.
The Canadian Journal of Cardiology|April 10, 2026
Impact of Assisted Reproductive Technologies in Women with Cardiovascular DiseaseArya Ardehali, Chelsea Williams, Sarah Monagle, et al.
Analytical Chemistry|February 14, 2024
Targeted Quantification of Proteoforms in Complex Samples by Proteoform Reaction MonitoringChe-Fan Huang, Jake T Kline, Fernanda Negrão, et al.
Clinical Transplantation|February 8, 2023
Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieuMyung-Ho Kim, Meghan E Sise, Min Xu, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Pageof 20